Cure TV

Recent research found that patients under 50 were less likely to have a treatment-determining biomarker than their older counterparts.

An expert discusses a trial comparing recombinant interferon alpha-2 with hydroxyurea in patients with myeloproliferative neoplasms (MPNs).

There are some key discussions that men with metastatic prostate cancer should have with their health care providers.

Lung cancer registries, like the Bonnie J. Addario Lung Cancer Foundation's, can be beneficial to patients and researchers.

Researchers should not give up hope in using immunotherapy to treat brain cancers.

As the number of patients and survivors continues to increase, it is important that clinician burnout is handled appropriately, explains Thomas A. Gallo.

It is important that advocacy organizations unify their message, says Mike Crosby, the founder of the Veterans Prostate Cancer Awareness group.

Some immunotherapy drugs target the PD-L1 protein, though this expert says that it is still an imperfect biomarker.

By getting their tumor genetically tested, a patient may find out that they are eligible for certain treatment options.

Over the past few decades, prostate cancer has become better understood and treated more effectively.

A two-drug regimen improved outcomes for patients with myeloma when given before a stem cell transplant.

The field of ovarian cancer is changing rapidly, and moving toward an era of precision medicine.

A lack of vitamin D can have major impacts on myeloma treatment outomes.

The science behind immunotherapy and gastrointestinal cancers is not quite perfected yet, but one subset of patients is seeing remarkable results.

The Leukemia & Lymphoma Society's (LLS) Clinical Trial Support Center helps patients with blood cancers find clinical trials that are right for them.

After finding out she had an MPN, Barbara Abernathy, Ph.D., like many other people, felt numb. But then it was time to find her fight mode.

Patients with non-muscle invasive bladder cancer experience high levels of distress, according to one study.

While there is no test, such as a mamogram or colonoscopy, for uterine cancer, vaginal bleeding is a telltale sign of the disease.

Many patients with ovarian cancer have misconceptions about the care they will receive while on a clinical trial, according to Laurel W. Rice, M.D.

While there are a few common and well-known checkpoints for bladder cancer, there are also many more than PD-1, PD-L1 and CTLA-4.

Yoga and Reiki can have great benefits for patients undergoing cancer treatment, according to Patrick Dempsey.

Patients with PV tend to be very symptomatic, but Jakafi can help.

When asked about her favorite thing about Thea's Star of Hope, the ten-year-old explained that the organization is like a laser on pediatric brain tumors, shooting at them until, hopefully one day, poof! They disappear.

The understanding of genetic mutations, like tumors that are microsatellite instability-high (MSI-H), and the therapies that go along with them is transforming the world of colorectal cancer, according to John Marshall, M.D.

William J. Gradishar, M.D., discusses the potential surgical implications for a woman with breast cancer who tests positive for a BRCA mutation, and why it is important to be aware of this genetic information.

The time has finally come when researchers have found a way to harness the immune system and use it to fight blood cancers.

Immunotherapy use continues to expand in the cancer treatment space. So, it is important that patients and caregivers understand its potential side effects.

The definition of smoldering myeloma was reworked in recent years.